Clinical Trials
Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study
UCB
PR-M03-19-NI-016Mar 07, 2019
FDA Approval
Bausch Health's BRYHALI™(halobetasol propionate) Lotion, 0.01%, Receives Tentative FDA Approval For Plaque Psoriasis In Adults
Bausch Health Companies Inc.
PR-M10-18-NI-033Oct 10, 2018
FDA
Johnson & Johnson Gets FDA Nod for New Treatment for Plaque Psoriasis
Nigel Walker
Nice Insight
PAO-M07-17-NI-023Jul 21, 2017